Which new health technologies do we need to achieve an end to HIV/AIDS?
Date
2016Author
Gray, Glenda E.
Laher, Fatima
Doherty, Tanya
Karim, Salim Abdool
Hammer, Scott
Mascola, John
Beyrer, Chris
Corey, Larry
Metadata
Show full item recordAbstract
In the last 15 years, antiretroviral therapy (ART) has been the most globally impactful lifesaving
development of medical research. Antiretrovirals (ARVs) are used with great success
for both the treatment and prevention of HIV infection. Despite these remarkable
advances, this epidemic grows relentlessly worldwide. Over 2.1 million new infections occur
each year, two-thirds in women and 240,000 in children. The widespread elimination of
HIV will require the development of new, more potent prevention tools. Such efforts are
imperative on a global scale. However, it must also be recognised that true containment of
the epidemic requires the development and widespread implementation of a scientific
advancement that has eluded us to date—a highly effective vaccine. Striving for such medical
advances is what is required to achieve the end of AIDS.